![]() |
PRACTICES |
Chemical Regulation under REACHOverview: Registration, Evaluation, Authorization and Restriction of Chemicals (REACH) is the European Union’s (EU) chemical management regulation. It is an ambitious chemical control initiative with significant duties placed on industry. Companies whose businesses are affected by REACH need skilled consultants and scientists who are not only familiar with the current regulatory framework, including the various laws that implement REACH, but who are also equipped, both in terms of skill set and experience, to guide clients successfully as the REACH framework continues to evolve. The end of the “registration deadlines” in 2018 marked the start of a new era under REACH, and this new phase includes a strong emphasis on information quality and compliance. Companies globally have taken measures to address REACH compliance, and they must now remain connected to manage the new and evolving REACH requirements and concerns of regulators. Various activities are ongoing in the REACH arena under each of the regulation’s specific processes, and chemical companies with business interests across the EU can benefit substantially from expert, well-informed, and timely REACH support. The Acta Group (Acta®) is uniquely well suited to navigate thousands of pages of rules and guidelines included in the REACH legal text, implementing regulations, and the European Chemicals Agency’s (ECHA) guidance documents. Our professionals have been, are, and will remain extensively involved in all aspects of REACH and can assist clients in complying with the REACH framework today -- and also in foreseeing future developments under REACH. Our Experience: Since REACH’s inception, Acta science, legal, and regulatory professionals have actively assessed the legislation and its implications and have prepared clients for its requirements. Our professionals include UK-based Manager, REACH, Emma Louise Jackson, CBiol MSB, who delivers skilled REACH assistance, including testing strategy advice, literature searching and reliability assessment, and compilation of regulatory documents, such as IUCLID 6 registration dossiers and Chemical Safety Reports (CSR), and Carolyn Wray, Regulatory Assistant, who assists with the preparation of legal agreements and provides support to clients and downstream users. Leading Acta’s science team is Jane S. Vergnes, Ph.D., DABT®. Dr. Vergnes, an esteemed toxicologist with an impressive track record of success directing global product stewardship for Fortune 500-listed chemical companies before joining Acta, has particular expertise in toxicological testing within the regulatory framework of REACH, including study design, laboratory practices, and data requirements for new chemical introductions, having started her career as a research scientist and laboratory supervisor. Acta’s scientific team includes Lara A. Hall, M.S., a Registered Quality Assurance Professional in Good Laboratory Practice (RQAP-GLP). Ms. Hall offers clients expertise in the monitoring, quality assurance, and interpretation of ecotoxicology, environmental fate, physical-chemical properties, product chemistry, and analytical method validation studies in support of submissions under REACH. Karin F. Baron, MSPH, Senior Regulatory Consultant at Acta, is instrumental in assisting our clients to obtain and maintain compliance under REACH. Ms. Baron supports comprehensively various clients as part of Acta’s Only Representative services, provides targeted training to Acta clients, and is an expert on classification and labeling. Karen L. Lorusso is a Regulatory Consultant with a focus on the classification and labeling of substances and mixtures. She has experience with submitting dossiers in REACH-IT and preparing dossiers in IUCLID 6. Scott J. Burya, Ph.D., a Regulatory Chemist with a Ph.D. in analytical chemistry, managed compliance programs and coordinated teams focused on commercializing new products for a multinational chemical corporation. Well versed in REACH physicochemical properties testing guidelines and requirements, Dr. Burya monitors GLP studies and prepares technical documentation to support registrations. What We Do:
Representative Engagements:
|
THE ACTA GROUP, L.L.C. 2200 Pennsylvania Ave, N.W. Suite 100W | Washington, D.C. 20037 | (202) 266-5020 | actagroup.com © 2023 The Acta Group All Rights Reserved |